Literature DB >> 20490678

Metformin: a therapeutic option for treating nonalcoholic fatty liver disease.

Ludovico Abenavoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20490678     DOI： 10.1007/s10620-010-1279-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study.

Authors:  G A Garinis; B Fruci; A Mazza; M De Siena; S Abenavoli; E Gulletta; V Ventura; M Greco; L Abenavoli; A Belfiore
Journal:  Int J Obes (Lond)       Date:  2010-02-23       Impact factor: 5.095

2.  A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.

Authors:  Elisabetta Bugianesi; Elena Gentilcore; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Ezio David; Mario Rizzetto; Giulio Marchesini
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

3.  Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.

Authors:  Claudia Pinto Marques Souza de Oliveira; José Tadeu Stefano; Erika Rabelo Forte de Siqueira; Leonardo Soares Silva; Daniel Ferraz de Campos Mazo; Vicência Mara Rodrigues Lima; Carlos Kioshi Furuya; Evandro Sobroza Mello; Fabrício G Souza; Fabíola Rabello; Telma Eugênio Santos; Monize Aydar Nogueira; Stephen H Caldwell; Venâncio Avancini Ferreira Alves; Flair José Carrilho
Journal:  Hepatol Res       Date:  2008       Impact factor: 4.288

Review 4.  Nonalcoholic fatty liver disease: a review and update.

Authors:  Jeffrey R Lewis; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.